New pharmaceutical account wins notified to us by the winning agency for the period March 2009 and April 2009 inclusive:
| CLIENT | PRODUCT | THERAPEUTIC AREA | WINNING AGENCY |
| Almirall | Solaraze | Dermatology | Signature Healthcare Communications |
| Celgene | Vidaza | Haematology | Succinct Healthcare Communications |
| EMD Serono | n/a | Infertility | Medaxial |
| Galderma | New product | Dermatology | Signature Healthcare Communications |
| Genzyme | Mozobil | Oncology | Medaxial |
| Genzyme | Thyrogen | endocrinology / oncology | Medaxial |
| Lifeblood: The Thrombosis Charity | National Thrombosis Awareness Week | Corporate | Athena |
| Mundipharma | Strategic planning processes and European Internal Comms engagement | Corporate | JYC Global |
| Napp Pharmaceuticals | Oxycontin | Palliative Care | Signature Healthcare Communications |
| Novartis global | Exelon patch | Neuroscience | Just:: |
| Novartis global* | Stalevo | Neuroscience | Just:: |
| Novartis | NHS engagement | Diabetes, Hypertension, CV | JYC Global |
| Novartis Oncology International | Zometa | Oncology | PraeMedica |
| Orchid | Male cancer awareness week | Corporate | Spink |
| Schering Plough | NHS project work | Cardiovascular | JYC Global |
| SKCIN | Corporate | Skin cancer | Signature Healthcare Communications |
*Clarification: it was not made clear in the April issue of PM that Just:: was hired by Novartis to work on global communications and that in the UK Stalevo is still marketed by Orion Pharma UK.
Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
Published: 08/06/2009
Area: Pharmaceutical marketing and communications articles| PRA expands its European operations with new UK and Dutch offices |
| Daiichi to research cancer drugs with Japan’s National Cancer Centre |